Benjamin Philipp E.
- Country
- Germany
- Department
- Oncology
Research Overview
- Efficacy and Safety of Bupivacaine Hydrochloride Monohydrate versus Lidocaine Hydrochloride for the Management of Oral Mucositis-Associated Pain in Head and Neck Cancer Patients
- Phase IIa Randomized, Double-Blind, Placebo-Controlled Study of ACOU085 for Prevention of Cisplatin-Induced Sensorineural Hearing Loss in Testicular Cancer Patients
Data & Insights
Has run more than one trial at 3 of 24 partner sites.
Specializations
Oncology & Auditory Health
This investigator specializes in the intersection of testicular cancer treatment and its effects on hearing health, with particular focus on preventing treatment-related auditory complications.
- Ototoxicity Prevention
- Cisplatin-Related Hearing Loss
- Protective Therapies
The research explores innovative approaches to maintaining auditory function in cancer patients undergoing chemotherapy treatments.
Hearing Protection Research
Focuses on developing protective strategies against sensorineural hearing loss, particularly in the context of cancer treatment protocols.
- Auditory Function Assessment
- Hearing Loss Prevention
- Therapeutic Interventions
Investigation centers on novel protective compounds and their potential to preserve hearing function during cancer treatment.
Clinical Applications
Studies the implementation of protective auditory treatments in clinical settings, specifically targeting patients receiving chemotherapy.
- Treatment Safety Evaluation
- Patient Monitoring Protocols
- Therapeutic Efficacy Assessment
Evaluates the practical application of hearing protection strategies in oncology treatment settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.